Clinical Trials Directory

Trials / Terminated

TerminatedNCT02041624

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis

An International Non-Interventional Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis Treated With Oralair®.

Status
Terminated
Phase
Study type
Observational
Enrollment
740 (actual)
Sponsor
Stallergenes Greer · Industry
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study is to describe patient's perception of quality of life and effectiveness of ORALAIR® over a follow-up period up to 5 years, in real-life settings.

Detailed description

Primary objective: To describe the patient's perception of the impact of ORALAIR® on his/her health related generic and disease specific quality of life during the grass pollen season in real-life settings. Secondary objectives: \- To describe the patient's perceived effectiveness of ORALAIR® in allergic rhinoconjunctivitis management in terms of disease intensity, satisfaction and rescue medication

Conditions

Timeline

Start date
2014-05-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2014-01-22
Last updated
2016-04-18

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02041624. Inclusion in this directory is not an endorsement.

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (NCT02041624) · Clinical Trials Directory